Acorah Software Products - Accounts Production 16.8.200 false true false true No description of principal activity 23 June 2024 30 June 2025 30 June 2025 15797476 Dr Khaula Safdar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15797476 2024-06-22 15797476 2025-06-30 15797476 2024-06-23 2025-06-30 15797476 frs-core:CurrentFinancialInstruments 2025-06-30 15797476 frs-bus:PrivateLimitedCompanyLtd 2024-06-23 2025-06-30 15797476 frs-bus:FilletedAccounts 2024-06-23 2025-06-30 15797476 frs-bus:Micro-entities 2024-06-23 2025-06-30 15797476 frs-bus:AuditExempt-NoAccountantsReport 2024-06-23 2025-06-30 15797476 frs-bus:Director1 2024-06-23 2025-06-30
Registered number: 15797476
Dr k Safdar Ltd
Unaudited Financial Statements
For the Period 23 June 2024 to 30 June 2025
Dr k Safdar Ltd
Balance Sheet
As At 30 June 2025
Balance Sheet
Registered number: 15797476

| 30 June 2025
--- | ---
|  | £
Current assets |  | 340
Creditors: Amounts Falling Due Within One Year |  | (4,647 )
NET CURRENT LIABILITIES |  | (4,307 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  | (4,307 )
Accruals and deferred income |  | (299 )
NET LIABILITIES |  | (4,606 )
CAPITAL AND RESERVES |  | (4,606 )

## Notes

1. General Information
Dr k Safdar Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15797476 . The registered office is 111 Charterhouse Street Charterhouse Street, London, EC1M 6AW.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Khaula Safdar Director
13th January 2026